Like its predecessor bills, the goal of AB-45 is to ‘legalize’ a plethora of hemp-derived products.
Although California has adopted one of the most robust medical and recreational marijuana programs (known as “cannabis” programs), and despite the enactment of the Agriculture Improvement Act of 2018 (the 2018 Farm Bill), the state can’t seem to convene specific legislation around the regulation and oversight of hemp-derived products.
Following the passage of the 2018 Farm Bill, state lawmakers attempted to pass AB-228, which intended to forge a legal pathway for many hemp-derived ingestible products in the state. While the bill made it pretty far, it ultimately died toward the end of the legislative session partially due to strong opposition.
In 2020, at the very end of the legislative session, California lawmakers tried to revive this issue by introducing AB-2028, which also failed to gather sufficient support.
Then, on the eve of this new year, the state legislature introduced a new CBD bill entitled, AB-45. Like its predecessor bills, the goal of AB-45 is to “legalize” a plethora of hemp-derived products. AB-45 contains many concepts originally found in AB-228 but adds some provisions, which, while intended to reach a compromise with former opponents of AB-228’s predecessors, will most certainly encounter opposition from the hemp industry.
Here is a high-level overview of some of the key provisions of AB-45:
Published: February 23, 2021
Founder & Interim Editor of L.A. Cannabis News